NCT06680856View on ClinicalTrials.gov

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

October 17, 2024

Study Completion Date

October 17, 2024

Conditions
Diabetic Foot UlcerSkin LesionsAllogeneicPRP
Interventions
COMBINATION_PRODUCT

PRP+HA

treatment of diabetic foot ulcers with allogeneic PRP+HA

COMBINATION_PRODUCT

HA

treatment of diabetic foot ulcers with HA

Trial Locations (2)

16132

IRCCS Ospedale San Martino, Genova

Unknown

Istituto dermatopatico dell'Immacolata, Roma

All Listed Sponsors
collaborator

IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti

OTHER

collaborator

Universita degli Studi di Genova

OTHER

lead

Ospedale Policlinico San Martino

OTHER

NCT06680856 - Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter